Laurence Champion
Orsay, 91400, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Response to "Beyond glucose uptake: rethinking PET/CT and hematologic markers for immune profiling in early breast cancer".
Journal: Annals of nuclear medicine
Published: September 12, 2025
Multimodal Imaging to Improve Patient Selection and Optimize Treatment Planning and Delivery for Patients Undergoing Reirradiation: A Scoping Review.
Journal: Current oncology reports
Published: July 17, 2025
Are [18F]FDG PET/CT imaging and cell blood count-derived biomarkers robust non-invasive surrogates for tumor-infiltrating lymphocytes in early-stage breast cancer?
Journal: Annals of nuclear medicine
Published: May 09, 2025
Measuring Total Metabolic Tumor Volume from 18F-FDG PET: A Reality Check.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 04, 2024
Beyond FAP: ANTXR1 as a novel target for PET imaging and radio-ligand therapy in immuno-oncology?
Journal: European journal of nuclear medicine and molecular imaging
Published: November 14, 2024
Pre-treatment [18F]FDG PET/CT biomarkers for the prediction of antibody-drug conjugates efficacy in metastatic breast cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 19, 2024
Optimizing lung cancer radiation therapy: A systematic review of multifactorial risk assessment for radiation-induced lung toxicity.
Journal: Cancer treatment reviews
Published: October 09, 2023
Curative high-dose reirradiation for patients with recurrent head and neck adenoid cystic carcinomas: outcomes and analysis of patterns of failure.
Journal: International journal of radiation biology
Published: August 01, 2023
Clinical Utility of Pre-Therapeutic [18F]FDG PET/CT Imaging for Predicting Outcomes in Breast Cancer.
Journal: Journal of clinical medicine
Published: June 26, 2023
PET/CT and SPECT/CT Imaging of HER2-Positive Breast Cancer.
Journal: Journal of clinical medicine
Published: June 15, 2023
[18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 22, 2023
Last Updated: 09/26/2026